A macrocyclic triene antibiotic that binds to and inhibits the molecular target of rapamycin (mTOR). It forms a complex with FKBP12 that binds to and inhibits the molecular target of rapamycin (mTOR). Rapamycin is a potent immunosuppressant and has anticancer activity
0.5 mg/mL in DMSO at ambient temperature
Rapamycin blocks certain blood cells that can reject foreign tissues and organs. It also blocks a protein that in involved in cell division. It is a type of antibiotic, a type of immunosupressant, and a type of serine/threonine kinase inhibitor. Rampamycin is now celled sirolimus.